Alpha-synuclein Levels in Cerebrospinal Fluid in Patients With Lewy Bodies Dementia and Other Neurodegenerative Disorders
Alpha-synuclein Levels in Cerebrospinal Fluid in Patients With Lewy Bodies Dementia and Other Neurodegenerative Disorders
复制标题
路易体痴呆和其他神经退行性疾病患者脑脊液中的 α-突触核蛋白水平
DOI:
10.1097/wad.0000000000000445
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Kawada T
中科院分区:
文献类型:
--
作者:
川原 瑞希;宮松 直美;清原 麻衣子;松本 みな美;佐田 みずき;久保 佐智美;久保田 芳美;西田 陽子;東山 綾;岡村 智教.;Kawada T
1. Mavroudis I, Petridis F, Chatzikonstantinou S, et al. Alpha-synuclein levels in the differential diagnosis of Lewy bodies dementia and other neurodegenerative disorders: a meta-analysis. Alzheimer Dis Assoc Disord. 2020; 34: 220–224. 2. Lim X, Yeo JM, Green A, et al. The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies—a systematic review and meta-analysis. Parkinsonism Relat Disord.2013; 19: 851–858. 3. Wang ZY, Han ZM, Liu QF, et al. Use of CSF α-synuclein in the differential diagnosis between Alzheimer’s disease and other neurodegenerative disorders. Int Psychogeriatr. 2015; 27: 1429–1438. 4. Kasuga K, Tokutake T, Ishikawa A, et al. Differential levels of alpha-synuclein, betaamyloid42 and tau in CSF between patients with dementia with Lewy bodies and